Sweden · Delayed Price · Currency is SEK CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of SEK 3.59 billion. The enterprise value is 3.43 billion.
| Market Cap | 3.59B |
| Enterprise Value | 3.43B |
Important Dates
The next confirmed earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
CellaVision AB has 23.85 million shares outstanding.
| Current Share Class | 23.85M |
| Shares Outstanding | 23.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 7.31% |
| Owned by Institutions (%) | 59.04% |
| Float | 19.72M |
Valuation Ratios
The trailing PE ratio is 23.47 and the forward PE ratio is 20.93. CellaVision AB's PEG ratio is 1.39.
| PE Ratio | 23.47 |
| Forward PE | 20.93 |
| PS Ratio | 4.73 |
| PB Ratio | 4.05 |
| P/TBV Ratio | 5.24 |
| P/FCF Ratio | 19.77 |
| P/OCF Ratio | 17.91 |
| PEG Ratio | 1.39 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.66, with an EV/FCF ratio of 18.87.
| EV / Earnings | 22.40 |
| EV / Sales | 4.52 |
| EV / EBITDA | 14.66 |
| EV / EBIT | 16.97 |
| EV / FCF | 18.87 |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.98 |
| Quick Ratio | 2.91 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.14 |
| Interest Coverage | 228.07 |
Financial Efficiency
Return on equity (ROE) is 17.97% and return on invested capital (ROIC) is 22.04%.
| Return on Equity (ROE) | 17.97% |
| Return on Assets (ROA) | 11.98% |
| Return on Invested Capital (ROIC) | 22.04% |
| Return on Capital Employed (ROCE) | 20.54% |
| Weighted Average Cost of Capital (WACC) | 10.36% |
| Revenue Per Employee | 3.29M |
| Profits Per Employee | 662,675 |
| Employee Count | 231 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, CellaVision AB has paid 41.19 million in taxes.
| Income Tax | 41.19M |
| Effective Tax Rate | 21.20% |
Stock Price Statistics
The stock price has decreased by -1.58% in the last 52 weeks. The beta is 1.12, so CellaVision AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -1.58% |
| 50-Day Moving Average | 150.44 |
| 200-Day Moving Average | 164.85 |
| Relative Strength Index (RSI) | 49.23 |
| Average Volume (20 Days) | 18,750 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of SEK 758.97 million and earned 153.08 million in profits. Earnings per share was 6.42.
| Revenue | 758.97M |
| Gross Profit | 519.88M |
| Operating Income | 202.07M |
| Pretax Income | 194.26M |
| Net Income | 153.08M |
| EBITDA | 221.67M |
| EBIT | 202.07M |
| Earnings Per Share (EPS) | 6.42 |
Balance Sheet
The company has 188.22 million in cash and 25.65 million in debt, with a net cash position of 162.57 million or 6.82 per share.
| Cash & Cash Equivalents | 188.22M |
| Total Debt | 25.65M |
| Net Cash | 162.57M |
| Net Cash Per Share | 6.82 |
| Equity (Book Value) | 887.58M |
| Book Value Per Share | 37.21 |
| Working Capital | 330.17M |
Cash Flow
In the last 12 months, operating cash flow was 200.53 million and capital expenditures -18.81 million, giving a free cash flow of 181.72 million.
| Operating Cash Flow | 200.53M |
| Capital Expenditures | -18.81M |
| Depreciation & Amortization | 19.59M |
| Net Borrowing | -14.97M |
| Free Cash Flow | 181.72M |
| FCF Per Share | 7.62 |
Margins
Gross margin is 68.50%, with operating and profit margins of 26.62% and 20.17%.
| Gross Margin | 68.50% |
| Operating Margin | 26.62% |
| Pretax Margin | 25.60% |
| Profit Margin | 20.17% |
| EBITDA Margin | 29.21% |
| EBIT Margin | 26.62% |
| FCF Margin | 23.94% |
Dividends & Yields
This stock pays an annual dividend of 2.75, which amounts to a dividend yield of 1.84%.
| Dividend Per Share | 2.75 |
| Dividend Yield | 1.84% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 38.95% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.82% |
| Earnings Yield | 4.26% |
| FCF Yield | 5.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CellaVision AB has an Altman Z-Score of 15.16 and a Piotroski F-Score of 7.
| Altman Z-Score | 15.16 |
| Piotroski F-Score | 7 |